Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Maxim receives SBIR grant for development of caspase-inducing drugs

Nov. 30, 2000

FeRx and Elan to develop MTC-DOX for treatment of liver cancer

Nov. 30, 2000

Deltagen obtains license to develop potential AML treatment

Nov. 30, 2000

Enhanced expression of p21 associated with responses to rAd-p53 gene therapy in NSCLC

Nov. 29, 2000

PK-11195 is able to sensitize cholangiocarcinoma cells to radiation-induced apoptosis

Nov. 29, 2000

Favorable pharmacokinetic and tolerability profile for Angiozyme in humans

Nov. 29, 2000

Antitumor agents from Spanish university induce apoptosis

Nov. 28, 2000

Oncologic Drugs Advisory Committee meeting in mid-December has a full agenda

Nov. 28, 2000

CI-1042 shows biological activity in refractory head and neck cancer

Nov. 28, 2000

Servier compares in vitro/in vivo antitumor activity of new olivacines to doxorubicin and VP-16

Nov. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...